TY - JOUR KW - 25-Hydroxyvitamin D3 1-alpha-Hydroxylase KW - Antimicrobial Cationic Peptides KW - Cells, Cultured KW - Humans KW - Interleukin-10 KW - Interleukin-1beta KW - leprosy KW - Leprosy, lepromatous KW - Leprosy, Tuberculoid KW - MicroRNAs KW - Monocytes KW - tratamento KW - Signal Transduction KW - Toll-Like Receptor 1 KW - Toll-Like Receptor 2 KW - Vitamin D KW - Beta-Defensins AU - Sarno E AU - Modlin RL AU - Rea T AU - Liu PT AU - Graeber T AU - Teles R AU - Wheelwright M AU - Edfeldt K AU - Ferguson B AU - Komisopoulou E AU - Mehta M AU - Vazirnia A AB -
Leprosy provides a model to investigate mechanisms of immune regulation in humans, given that the disease forms a spectrum of clinical presentations that correlate with host immune responses. Here we identified 13 miRNAs that were differentially expressed in the lesions of subjects with progressive lepromatous (L-lep) versus the self-limited tuberculoid (T-lep) disease. Bioinformatic analysis revealed a significant enrichment of L-lep-specific miRNAs that preferentially target key immune genes downregulated in L-lep versus T-lep lesions. The most differentially expressed miRNA in L-lep lesions, hsa-mir-21, was upregulated in Mycobacterium leprae-infected monocytes. By directly downregulating Toll-like receptor 2/1 heterodimer (TLR2/1)-induced CYP27B1 and IL1B expression as well as indirectly upregulating interleukin-10 (IL-10), hsa-mir-21 inhibited expression of the genes encoding two vitamin D-dependent antimicrobial peptides, CAMP and DEFB4A. Conversely, knockdown of hsa-mir-21 in M. leprae-infected monocytes enhanced expression of CAMP and DEFB4A and restored TLR2/1-mediated antimicrobial activity against M. leprae. Therefore, the ability of M. leprae to upregulate hsa-mir-21 targets multiple genes associated with the immunologically localized disease form, providing an effective mechanism to escape from the vitamin D-dependent antimicrobial pathway.
BT - Nature medicine C1 - http://www.ncbi.nlm.nih.gov/pubmed/22286305?dopt=Abstract C2 - USA CY - New York DA - 2012 Jan 29 DO - 10.1038/nm.2584 IS - 2 J2 - Nat. Med. LA - eng N2 -Leprosy provides a model to investigate mechanisms of immune regulation in humans, given that the disease forms a spectrum of clinical presentations that correlate with host immune responses. Here we identified 13 miRNAs that were differentially expressed in the lesions of subjects with progressive lepromatous (L-lep) versus the self-limited tuberculoid (T-lep) disease. Bioinformatic analysis revealed a significant enrichment of L-lep-specific miRNAs that preferentially target key immune genes downregulated in L-lep versus T-lep lesions. The most differentially expressed miRNA in L-lep lesions, hsa-mir-21, was upregulated in Mycobacterium leprae-infected monocytes. By directly downregulating Toll-like receptor 2/1 heterodimer (TLR2/1)-induced CYP27B1 and IL1B expression as well as indirectly upregulating interleukin-10 (IL-10), hsa-mir-21 inhibited expression of the genes encoding two vitamin D-dependent antimicrobial peptides, CAMP and DEFB4A. Conversely, knockdown of hsa-mir-21 in M. leprae-infected monocytes enhanced expression of CAMP and DEFB4A and restored TLR2/1-mediated antimicrobial activity against M. leprae. Therefore, the ability of M. leprae to upregulate hsa-mir-21 targets multiple genes associated with the immunologically localized disease form, providing an effective mechanism to escape from the vitamin D-dependent antimicrobial pathway.
PB - Nature Publishing Company PP - New York PY - 2012 SP - 267 EP - 73 T2 - Nature medicine TI - MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. VL - 18 SN - 1546-170X ER -